HRVATSKA UDRUGA LEUKEMIJA I LIMFOMI (HULL) DONOSI OBAVIJESTI O ODRŽANIM AKTIVNOSTIMA I SKUPU POD NAZIVOM EUROPEAN PATIENT INNOVATION SUMMITU 2020 (EPIS 2020)

Tijekom 2020. godine u organizaciji tvrtke Novartis nastavile su se aktivnosti pod nazivom EPIS, a koje su se, obzirom na epidemiološku situaciju, održale u virtualnom obliku.

U nastavku možete pogledati o kakvim se je aktivnostima radilo te se informirati o novostima, digitalnom povezivanju i unapređivanju rada, a što će pomoći samim pacijentima, kao udrugama pacijenata općenito (EPIS 2020 Newsletter 5).

Dražen Vincek

 

We would also like to take this opportunity to remind you of the final event of the EPIS virtual event series, the webinar on February 25th 2021. This session will focus on making our recommendations a reality and will also include the launch of the EPIS 2020 official toolkit!

We hope that you have found these past few weeks engaging and that you have gained valuable knowledge, which you can bring back to your patient communities.

Stay tuned as we update the official EPIS website with all the relevant materials from the sessions: www.EPISummit.net

A reminder that you can also find the recordings and slides from all of the sessions right now on www.EPIS2020.com
The recordings are available in the menu and the slides in the agenda section!

We wish you all a wonderful rest of the year and look forward to connecting with you again in 2021.

Kind regards,
The EPIS Team

GLNS/NEUR/0067g
Date of Preparation: October 2020

Organized and funded by Novartis

 

Dear Patient Advocates,

A final massive thank you to all of you for joining the EPIS 2020 event series! It has been an adventure and great learning opportunity to go completely virtual for this years’ EPIS and we hope you have enjoyed being on this journey with us.

Please find below our sketchnote visual that summarizes the meeting. Among other things, it illustrates the actions that the stakeholders should take to ensure that patients continue to benefit from digital engagement opportunities. These were agreed upon in our consensus building session and will be an important part of building the output of this years’ event.
 

Sketchnote 5th Nov